Department of Molecular Oncology
|Ragnhild A. Lothe||Rolf I. Skotheim||Guro E. Lind|
A Norwegian Centre of Excellence funded by the Research Council of Norway.
|Norwegian Cancer Genomics Consortium|
Leader of the National Cancer Genomics Consortium, professor Ola Myklebost, and colleagues professors Per Eystein Lønning, Bjørn Tore Gjertsen and Ragnhild A. Lothe point out that in "personalized medicine", cancer patients remain the largest and increasing group that may benefit most from new treatment strategies. The authors emphasize the importance of increase in national clinical trials and participation in high quality international studies for the benefit of the Norwegian cancer patient and to strengthen the Norwegian professional development and research.
Modern genome technologies can give in-depth analysis of cancer cells that until recently was merely science fiction. However, this generates enormous amounts of data points, and researchers at the Department of Molecular Oncology meet these heavy computation challenges with informatics experts and supercomputers. This development in cancer research was the topic of an interview with Group leader Rolf Skotheim in the weekly magazine Vi Menn this summer.
Vi Menn - Tungregning og big data
Department of Molecular Oncology, Institute for Cancer Research
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 2278 1728, Switchboard: +47 2293 4000, Fax: +47 2278 1745